医学
放射性肺炎
肺癌
医学物理学
放射治疗
重症监护医学
病理
放射科
作者
Yaoyao Zhu,Yujie Yan,Jiamei Fu,Qing Shao,Ying Zhang,Xiaoshuai Yuan,Jingjing Kang,Min Hu,Chenxue Jiang,Minren Hu,Ruifeng Zhao,Lan Zhao,Yaping Xu,Shuangyan Yang
标识
DOI:10.21037/tlcr-2025-151
摘要
Risk factor prevention and standardized treatment could decrease the occurrence of SRP. Clinicians should implement the recommendations in the RP management consensus in clinical practice. Special attention should be given to patients with identifiable risk factors such as pre-existing ILD, compromised lung function, high radiotherapy dose and low lymphocyte baseline counts, to improve patient prognosis and treatment safety.
科研通智能强力驱动
Strongly Powered by AbleSci AI